Back to TMO
Compagnie Lombard Odier SCmA → TMO
Compagnie Lombard Odier SCmA TMO Position History
Thermo Fisher Scientific Inc. • Healthcare
Quarters held
16
Latest value
$31.7M
Q3 2026
Peak value
$172.6M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $2.1M |
| Q3 2025 | $113.7M |
| Q3 2025 | $26.8M |
| Q4 2025 | $2.8M |
| Q4 2025 | $144.9M |
| Q4 2025 | $25.9M |
| Q1 2026 | $4.4M |
| Q1 2026 | $119.9M |
| Q1 2026 | $22.8M |
| Q2 2026 | $4.6M |
| Q2 2026 | $131.9M |
| Q2 2026 | $23.9M |
| Q2 2026 | $0 |
| Q3 2026 | $3.9M |
| Q3 2026 | $172.6M |
| Q3 2026 | $31.7M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $31.7M | 46.9K | — | — |
| Q3 2026 | $172.6M | 255.7K | — | — |
| Q3 2026 | $3.9M | 5.8K | — | — |
| Q2 2026 | $0 | 0 | — | — |
| Q2 2026 | $23.9M | 47.7K | — | — |
| Q2 2026 | $131.9M | 263.0K | — | — |
| Q2 2026 | $4.6M | 9.1K | — | — |
| Q1 2026 | $22.8M | 46.5K | — | — |
| Q1 2026 | $119.9M | 243.9K | — | — |
| Q1 2026 | $4.4M | 8.9K | — | — |
| Q4 2025 | $25.9M | 44.8K | — | — |
| Q4 2025 | $144.9M | 250.0K | — | — |
| Q4 2025 | $2.8M | 4.9K | — | — |
| Q3 2025 | $26.8M | 55.2K | — | — |
| Q3 2025 | $113.7M | 234.3K | — | — |
| Q3 2025 | $2.1M | 4.2K | — | — |